Skip to main content
. 2016 Jun 24;95(25):e3865. doi: 10.1097/MD.0000000000003865

Figure 2.

Figure 2

A, Kaplan–Meier analyses of OS and PFS for different breast cancer subtypes. B, Kaplan–Meier analyses of OS for different breast cancer subtypes by early- or late-stage disease. C, Kaplan–Meier analyses of PFS for different breast cancer subtypes by early- or late-stage disease. 95% CI = 95% confidence interval, HR = hazard ratio, HER2 = human epidermal growth factor 2, MFS = metastasis-free survival, OS = overall survival, PFS = progression-free survival, RFS = recurrence-free survival, TNBC = triple negative breast cancer.